D-Wave Advantage2 (Quantum Annealing Platform)

D-Wave occupies a unique and commercially significant position in the 2026 quantum landscape: it is the only quantum computing company achieving truly widespread, production-level enterprise deployment. D-Wave's Advantage2 system — a 4,400+ qubit quantum annealer generally available since May 2025 — is running live in production workflows for customers in logistics, defense, healthcare, and financial services. Customer usage of Advantage2 systems increased by 314% year-over-year in 2025, and hybrid solver usage grew 114% in just six months. D-Wave's quantum annealing paradigm finds the minimum energy configuration of a physical system that encodes an optimization problem, making Advantage2 exceptionally powerful for combinatorial optimization. The system delivers doubled coherence time versus its predecessor and a 40% increase in energy scale. PolarisQB's QuADD platform on D-Wave Advantage reduced early-stage drug design from years to hours by exploring up to 10^30 candidate molecules, and in a January 2026 benchmark outperformed the AI-based BInD system on both binding affinity and synthetic complexity scores — the first documented case of a quantum system besting a state-of-the-art AI model on a drug discovery task. Defense applications include partnerships with Anduril Industries and Davidson Technologies on missile-defense trajectory optimization, reporting a 10x speedup. D-Wave's Leap cloud provides flexible monthly subscription access from $3,000 per month.